Drug Trial Radar · NCT06533644
A Study of SYNC-T Therapy SV-102 in Participants With Metastatic Castration-Resistant Prostate Cancer
Last checked: Nov 19, 2026Latest source record: Jun 23, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
91
Planned (sponsor's estimate)
Start
May 29, 2025
Primary completion
Apr 14, 2028
Study completion Apr 14, 2028
Sponsor
- Lead sponsor
- Syncromune, Inc.Industry
- Sponsor type
- Industry
- First posted
- Aug 1, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Sequential
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- Male only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary purpose of this study is to evaluate the safety, tolerability, and efficacy of SYNC-T Therapy SV-102 and to identify the maximum tolerated dose (MTD) and/or selected dose for phase 2b study.
Conditions
- Metastatic Castration-resistant Prostate Cancer
Interventions
Partial OncolysisProcedure
Partial tumor oncolysis will be completed by cryolysis.
SV-102Drug
Intratumoral infusion of SV-102
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With Adverse Events (AEs), Serious Adverse Events (SAEs), Treatment-Emergent Adverse Events (TEAEs), Serious TEAEs and Immune-related Adverse Reactions (imARs)Time frame: Up to 2 years
- Maximum Tolerated DoseTime frame: Up to 48 weeks
- Optimal Biologic Dose (OBD)Time frame: Up to 48 weeks
- Recommended Phase 2 Dose (RP2D)Time frame: Up to 48 weeks
- Objective Response Rate (ORR)Time frame: Up to 2 years
Locations
23 sites in 1 country. Site status is shown where the registry gives one.
Mayo Clinic
Phoenix, Arizona · Not yet recruiting
University of Arizona Cancer Center
Tucson, Arizona · Recruiting
Arkansas Urology
Little Rock, Arkansas · Not yet recruiting
University of California-Davis
Sacramento, California · Recruiting
Mayo Clinic
Jacksonville, Florida · Not yet recruiting
University of Miami
Miami, Florida · Recruiting
Moffitt Cancer Center
Tampa, Florida · Recruiting
University of Chicago
Chicago, Illinois · Not yet recruiting
Duly Health
Lisle, Illinois · Recruiting
Wichita Urology
Wichita, Kansas · Recruiting
Willis Knighton
Shreveport, Louisiana · Not yet recruiting
Michigan Institute of Urology
Troy, Michigan · Recruiting
Mercy Hospital
St Louis, Missouri · Recruiting
University of Nebraska Medical Center
Omaha, Nebraska · Recruiting
Northwell Health
Lake Success, New York · Recruiting
NYU Langone
New York, New York · Recruiting
Weill Cornell
New York, New York · Recruiting
Ohio State University
Columbus, Ohio · Recruiting
Thomas Jefferson University
Philadelphia, Pennsylvania · Not yet recruiting
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania · Recruiting
Houston Metro Urology
Houston, Texas · Not yet recruiting
Summit Urology
Murray, Utah · Not yet recruiting
Medical College of Wisconsin
Milwaukee, Wisconsin · Not yet recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.